The need for genetic services in hereditary cancer continues to grow. Innovative service delivery models, such as telegenetics, can leverage technology to improve access. Education of nongenetics ...
Comprehensive biomarker testing is crucial for NSCLC treatment, yet disparities exist between academic and community settings ...
The world has witnessed the roll out of multiple effective COVID-19 vaccines. Yet, COVID-19 continues to be an unprecedented challenge, unpinning societies, economies, and health systems. While ...
The Covid-19 pandemic has shown the whole world the critical importance of access to diagnostic testing. Typically, vaccines and medicines get a lot of attention in global health, but tests are ...
Despite this, universal genetic screening has not been recommended for several reasons. First, presence of the mutation does not mean that the individual will develop HH. Although testing may assist ...
The disease is hitting Black and Latino communities hardest. When the coronavirus outbreak threatened to rock Philadelphia’s predominantly Black neighborhoods, Dr. Ala Stanford knew that access to ...
STAMFORD, Conn.--(BUSINESS WIRE)--GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced Biogen (Nasdaq: BIIB), Praxis Precision Medicines ...
Germline genetic testing is now routinely recommended for patients with prostate cancer (PCa) because of expanded guidelines and options for targeted treatments. However, integrating genetic testing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results